United Therapeutics (UTHR) Misses Q4 EPS by 49c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $516.15 +1.13%
Revenue Growth %: -1.2%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -1.2%
Financial Fact:
Basic (in shares): 43.2M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q4 EPS of $6.19, $0.49 worse than the analyst estimate of $6.68. Revenue for the quarter came in at $735.9 million versus the consensus estimate of $739.92 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
- UBS Reiterates Buy Rating on Cheniere Energy (LNG)
- Designer Brands (DBI) PT Lowered to $6 at UBS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
